Our Company
About
Management
Board of Directors
Scientific Advisors
Collaborations
Our Technology
CD6 in Immuno-inflammation
EQ001
Publications
Pipeline
Overview
Therapeutic Applications
Graft-Versus-Host Disease
Uncontrolled Asthma
Lupus Nephritis
Clinical Trials
Our commitment to patients
The EQUATE study
Expanded Access Policy
Investors
Investor Overview
Stock Information
Stock Quote & Chart
News
Events & Presentations
Financials & Filings
SEC Filings
Corporate Governance
Governance Highlights
Management
Board Of Directors
Committee Composition
Investor FAQ
Contacts
Contacts
Email Alerts
Document Requests
Contact Us
Menu
HARNESSING NOVEL IMMUNOBIOLOGY
Scroll to top
